OpenClinica emerges as fastest-growing open source software choice for clinical trials

WALTHAM, Mass.--(BUSINESS WIRE)--OpenClinica is the fastest growing open source software choice for clinical trials, according to data released by the company. Started in 2005 by Harvard alums Cal Collins and Ben Baumann, OpenClinica is already the world's most popular open source software for web-based electronic data capture (EDC) and clinical data management (CDM).

Over the last year, the number of clinical trials powered by OpenClinica has grown 250 percent and it is now believed there are over 400 active production implementations worldwide, according to Ben Baumann, Director of Business Development for OpenClinica. A single implementation can support multiple trials.

"Given the need for a flexible, high quality electronic data capture solution that can be readily adapted to various settings, the rapid uptake of OpenClinica makes sense," said Baumann. "But, we did not expect usage of our Enterprise Edition to triple in just one year. That shows tremendous confidence in our products by the clinical research community."

Since 2010, Baumann says there has been a 10-fold increase in OpenClinica-powered trials that were part of submissions to regulatory agencies like the FDA. The growth is also indicated in the number of people and organizations that have joined the OpenClinica online community-now over 12,000.

Baumann believes the innovations in the forthcoming OpenClinica 3.1 software will continue to drive adoption and growth. Innovation is one of the themes for the Drug Information Association's 47th Annual Meeting in Chicago, which kicks-off on June 19, 2011. OpenClinica will be exhibiting at the conference at Booth 1843.

About OpenClinica®

OpenClinica enhances the productivity of clinical trials through commercial open source software. Trusted by hundreds of biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, the OpenClinica software facilitates electronic data capture and data management, increasing the speed of collection and quality of data in clinical trials. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. For more information - including product downloads - visit http://www.openclinica.com or follow @OpenClinica on Twitter.

Suggested Articles

Combining inhibitors of KRAS-G12C, mTOR and IGF1R can significantly shrink lung tumors in mice and human cancer cells, a study found.

X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, who founded the company alongside CEO Paula Ragan and biotech luminary Henri Termeer.

Henlius Biotech missed the $477 million goal it set for its IPO, but still made the top five biopharma IPOs this year with its $410 million listing.